Blood-retinal barriers in juvenile diabetics in relation to early clinical manifestations, HLA-DR types, and metabolic control

@article{Kernell1985BloodretinalBI,
  title={Blood-retinal barriers in juvenile diabetics in relation to early clinical manifestations, HLA-DR types, and metabolic control},
  author={Anna Kernell and Johnny Ludvigsson},
  journal={Graefe's Archive for Clinical and Experimental Ophthalmology},
  year={1985},
  volume={222},
  pages={250-253}
}
Eighty-seven diabetics 8.5–26 years old (mean ± SD 15.3 ± 3.9) and 32 healthy non-diabetic controls 8–27 years old (13.9 ± 4.3) were included in the study. They had had the disease for 2 months to 19 years (5.8–4.0 years). Seventy-two of the diabetic patients were HLA-DR type, 13 patients had DR 3 alone, 25 DR4, 33 DR 3,4 and 1 patient was neither DR 3 nor… CONTINUE READING